This is of particular importance because significantly elevated plasma concentrations of Il-18 have been confirmed in patients with CAD, and IL-18 itself has the ability to modulate the activity of various transcription factors, such as, inter alia, NF-kB [74]. This evidence concerns the gene IL18 and coronary artery disorder.